Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

MK-1775 (AZD1775) - WEE1 Inhibitor. CAS# 955365-80-7 Catalog No.:M60299-2S Smiles: CN([C@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O)OC)[C@@H](C)CC)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C

SKU: 78257527949

4.9
PLN45.00 PLN80.00

Pay in 4 interest-free payments of $11.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

MK-1775 (AZD1775) - WEE1 Inhibitor. CAS# 955365-80-7 Catalog No.:M60299-2S Smiles: CN([C@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O)OC)[C@@H](C)CC)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)CMK 1775 (AZD1775), CAS No. 955365 80 7, is a highly potent, selective and orally bioavailable Wee1 kinase inhibitor with IC50 of 5. 2 nM. It abrogated DNA damaged checkpoints induced by gemcitabine, carboplatin, and cisplatin etc. and enhanced the anti tumor efficacy of these agents selectively in p53 deficient tumor cells. At tolerated doses, MK 1775 treatment leads to xenograft tumor growth inhibition or regression. It inhibits Wee1 in H3K36me3

Store: skntheory.com · Domain: skntheory.com

Description

Smiles: CN([C@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O)OC)[C@@H](C)CC)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C

GNF-2 dose-dependently inhibited the proliferation of osteoclast precursors through the suppression of the M-CSFR c-Fms

Xcessbio is delighted to present you compound libraries

Quizartinib inhibits FLT3 with low nanomolar potency in cellular assays and is highly selective when screened against the majority of the human protein kinome

competitive and cell permeable prolyl 4-hydroxylase (P4H) inhibitor

MK-1775 (AZD1775) - WEE1 Inhibitor. CAS# 955365-80-7 Catalog No.:M60299-2S Smiles: CN([C@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O)OC)[C@@H](C)CC)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)CMK 1775 (AZD1775), CAS No. 955365 80 7, is a highly potent, selective and orally bioavailable Wee1 kinase inhibitor with IC50 of 5. 2 nM. It abrogated DNA damaged checkpoints induced by gemcitabine, carboplatin, and cisplatin etc. and enhanced the anti tumor efficacy of these agents selectively in p53 deficient tumor cells. At tolerated doses, MK 1775 treatment leads to xenograft tumor growth inhibition or regression. It inhibits Wee1 in H3K36me3

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products